V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214543 | 20168257 | 1.58 | 64.7 | null | 2020-03-05 | 2020-03-14 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100411732 |
| 20214548 | 20168258 | 1.7 | 100 | null | 2017-09-29 | 2017-09-29 | Capecitabine + Carboplatin + RT | 02 | null | CAPECITABINE + CARBOPLATIN | 100269889 |
| 20214566 | 20168259 | 1.88 | 63.1 | null | 2020-02-03 | 2020-02-15 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 101796512 |
| 20214568 | 20168260 | 1.62 | 64 | Adjuvant (A) | 2018-08-15 | 2018-08-20 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101573049 |
| 20214570 | 20168261 | 1.59 | 63 | Palliative (P) | 2016-11-21 | 2016-11-23 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CARBOPLATIN | 100236251 |
| 20214575 | 20168262 | 1.74 | 65 | null | 2021-02-18 | 2021-03-16 | Cape+Cisplatin+Trastuzumab Main | N | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101812671 |
| 20214576 | 20168263 | 1.71 | 99.1 | null | 2016-08-30 | 2016-08-30 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101854345 |
| 20214578 | 20168264 | 1.8 | 46.6 | Neo-adjuvant (N) | 2020-07-01 | 2020-11-11 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 100931639 |
| 20214582 | 20168265 | 1.73 | 53.1 | Adjuvant (A) | 2021-10-20 | 2022-05-16 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101265402 |
| 20214583 | 20168266 | 1.65 | 84 | Palliative (P) | 2021-03-16 | 2021-03-25 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101551641 |
| 20214585 | 20168267 | 1.62 | 67.8 | Palliative (P) | 2019-08-14 | 2019-12-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100678103 |
| 20214586 | 20168268 | 1.7 | 75.4 | Palliative (P) | 2021-12-03 | 2022-02-12 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CARBOPLATIN | 101070019 |
| 20214601 | 20168269 | 1.71 | 54.5 | Adjuvant (A) | 2016-11-14 | 2016-12-04 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101834614 |
| 20214607 | 20168270 | 1.72 | 61.3 | null | 2020-01-04 | 2020-01-18 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100330870 |
| 20214612 | 20168271 | 1.73 | 51.96 | Palliative (P) | 2021-12-11 | 2021-12-11 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100825920 |
| 20214619 | 20168272 | 1.8 | 43.5 | Palliative (P) | 2017-11-09 | 2017-12-06 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100602166 |
| 20214624 | 20168273 | 1.72 | 106.3 | Curative (C) | 2019-03-27 | 2019-04-12 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100666496 |
| 20214627 | 20168274 | 1.72 | 51.5 | Palliative (P) | 2019-03-01 | 2019-03-10 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 101833304 |
| 20214629 | 20168275 | 1.8 | 68.35 | null | 2014-03-27 | 2016-10-29 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101453309 |
| 20214633 | 20168276 | 1.82 | 66 | Curative (C) | 2016-04-27 | 2016-08-15 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100171147 |
| 20214639 | 20168277 | 1.51 | 107.5 | Palliative (P) | 2021-01-16 | 2021-09-19 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101060334 |
| 20214641 | 20168278 | 1.52 | 99.7 | null | 2020-02-17 | 2020-03-31 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100831800 |
| 20214643 | 20168279 | 1.65 | 85.9 | Palliative (P) | 2016-11-03 | 2016-12-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101108529 |
| 20214654 | 20168280 | 1.61 | 97 | Palliative (P) | 2021-12-02 | 2021-12-19 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100372165 |
| 20214655 | 20168281 | 1.82 | 40.15 | Palliative (P) | 2017-11-03 | 2017-11-03 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CARBOPLATIN | 101085675 |
| 20214656 | 20168282 | 1.7 | 93.4 | Adjuvant (A) | 2019-04-20 | 2019-05-06 | ECX | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100471389 |
| 20214659 | 20168283 | 1.71 | 75 | Adjuvant (A) | 2020-05-31 | 2020-05-31 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100013801 |
| 20214675 | 20168284 | 1.57 | 76.4 | Palliative (P) | 2020-01-06 | 2020-03-16 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100987455 |
| 20214677 | 20168285 | 1.76 | 82.6 | null | 2019-04-02 | 2019-04-15 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100153133 |
| 20214679 | 20168286 | 1.74 | 86.1 | Adjuvant (A) | 2021-09-09 | 2021-09-22 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101421218 |
| 20214681 | 20168287 | 1.63 | 52.2 | Palliative (P) | 2020-08-08 | 2020-09-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101226955 |
| 20214684 | 20168288 | 1.65 | 56.9 | Curative (C) | 2017-05-14 | 2017-05-14 | HCX (Cape + Cisp + Tras) - Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101868005 |
| 20214687 | 20168289 | 1.72 | 54.9 | Palliative (P) | 2021-10-21 | 2021-10-21 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100121366 |
| 20214688 | 20168290 | 1.81 | 102 | Palliative (P) | 2020-07-21 | 2020-11-06 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CARBOPLATIN | 100372480 |
| 20214692 | 20168291 | 1.56 | 52 | null | 2020-06-20 | 2020-07-04 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100944929 |
| 20214698 | 20168292 | 1.85 | 77 | Curative (C) | 2017-06-14 | 2017-06-17 | ECX | 02 | y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101735652 |
| 20214708 | 20168293 | 1.72 | 77 | Palliative (P) | 2017-12-19 | 2018-04-27 | ECX | N | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101265338 |
| 20214717 | 20168294 | 1.74 | 78 | Palliative (P) | 2018-04-14 | 2018-04-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100161978 |
| 20214718 | 20168295 | 1.8 | 80.45 | Adjuvant (A) | 2017-07-20 | 2017-07-22 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100390145 |
| 20214719 | 20168296 | 1.74 | 100.5 | Palliative (P) | 2018-03-03 | 2018-03-17 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100220145 |
| 20214747 | 20168297 | 1.6 | 68.2 | Palliative (P) | 2016-07-03 | 2016-07-27 | HCX (Cape + Cisp + Tras) - Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100230578 |
| 20214749 | 20168298 | 1.95 | 88 | Palliative (P) | 2018-09-29 | 2018-10-13 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100828400 |
| 20214753 | 20168299 | 1.51 | 67 | Palliative (P) | 2017-04-09 | 2017-06-11 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101057540 |
| 20214758 | 20168300 | null | 57 | null | 2020-10-21 | 2020-10-28 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101584995 |
| 20214759 | 20168301 | 1.74 | 76.3 | Palliative (P) | 2021-09-02 | 2021-10-23 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100127898 |
| 20214760 | 20168302 | 1.55 | 56.9 | Adjuvant (A) | 2017-07-24 | 2017-07-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101693353 |
| 20214763 | 20168303 | 1.7 | 39 | Curative (C) | 2018-07-15 | 2018-10-09 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | y | CAPECITABINE + CARBOPLATIN | 101470973 |
| 20214765 | 20168304 | 1.55 | 83 | Palliative (P) | 2017-10-18 | 2017-10-18 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100931637 |
| 20214769 | 20168305 | 1.68 | 106.9 | Palliative (P) | 2020-07-07 | 2020-07-07 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100119992 |
| 20214770 | 20168306 | 1.73 | 77 | Palliative (P) | 2021-02-24 | 2022-04-26 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101565793 |